81 results
·
16ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN(R)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN®
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN(R)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN(R)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN® (sodium hyaluronate)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN(R)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN®
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN®
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer
FDA classification
FDA Class 3
·Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1(SP142) Assay.
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA classification
FDA Class 3
·Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
Automated External Defibrillators (Non-Wearable)
FDA classification
FDA Class 3
·Automated External Defibrillators (Non-Wearable)